Historical record - last NADAC effective date: 8/21/2019
Product Information
QUETIAPINE FUMARATE 100 MG TAB is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0562 per EA under NDC 00054022120. Its NADAC has been published 286 times since Mar 12, 2014.
FDA first approved this application on Mar 27, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054022120
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/21/2019
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA090749FDA Approved
3/27/2012
TE Code
AB
On Market Since
3/27/2012
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE FUMARATE 100 MG TAB has been published 286 times since Mar 12, 2014, and over the history we have for it it has declined 69.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0562 per EA |
|---|---|
| All-time high | $0.1851 (Apr 16, 2014) |
| All-time low | $0.0562 (Aug 21, 2019) |
| Median price | $0.1158 |
| Average price | $0.1194 |
| Largest weekly change | -15.4% (May 18, 2016) |
| Weeks tracked | 286 |
| Tracking since | Mar 12, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-69.2%
Last surveyed Aug 28, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUETIAPINE FUMARATE 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE FUMARATE 100 MG TAB, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0562 per EA (NDC 00054022120), effective Aug 28, 2019.
How has the price of QUETIAPINE FUMARATE 100 MG TAB changed over time?
Over the history we have for it, the NADAC for QUETIAPINE FUMARATE 100 MG TAB has declined 69.2%. It has been tracked across 286 weekly CMS publications since Mar 12, 2014.
What are the highest and lowest recorded NADAC prices for QUETIAPINE FUMARATE 100 MG TAB?
Since Mar 12, 2014, the NADAC for QUETIAPINE FUMARATE 100 MG TAB has ranged from a low of $0.0562 (Aug 21, 2019) to a high of $0.1851 (Apr 16, 2014), with a median of $0.1158 per EA.
Are there cheaper alternatives to QUETIAPINE FUMARATE 100 MG TAB?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 100 MG TAB, is $0.0493 per EA — about 12% below QUETIAPINE FUMARATE 100 MG TAB.
Who manufactures QUETIAPINE FUMARATE 100 MG TAB?
QUETIAPINE FUMARATE 100 MG TAB (NDC 00054022120) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.